Literature DB >> 22616095

Immunomodulators: Cell savers.

Sarah DeWeerdt.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22616095     DOI： 10.1038/485s4a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  Preliminary studies related to anti-interleukin-1β therapy in children with newly diagnosed type 1 diabetes.

Authors:  Kathryn M Sumpter; Soumya Adhikari; Ellen K Grishman; Perrin C White
Journal:  Pediatr Diabetes       Date:  2011-04-24       Impact factor: 4.866

2.  GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.

Authors:  Johnny Ludvigsson; David Krisky; Rosaura Casas; Tadej Battelino; Luis Castaño; James Greening; Olga Kordonouri; Timo Otonkoski; Paolo Pozzilli; Jean-Jacques Robert; Henk J Veeze; Jerry Palmer; Ulf Samuelsson; Helena Elding Larsson; Jan Åman; Gunilla Kärdell; Jan Neiderud Helsingborg; Göran Lundström; Eva Albinsson; Annelie Carlsson; Maria Nordvall; Hans Fors; Carl-Göran Arvidsson; Stig Edvardson; Ragnar Hanås; Karin Larsson; Björn Rathsman; Henrik Forsgren; Helena Desaix; Gun Forsander; Nils-Östen Nilsson; Carl-Göran Åkesson; Päivi Keskinen; Riitta Veijola; Timo Talvitie; Klemens Raile; Thomas Kapellen; Walter Burger; Andreas Neu; Ilse Engelsberger; Bettina Heidtmann; Suzanne Bechtold; David Leslie; Francesco Chiarelli; Alesandro Cicognani; Giuseppe Chiumello; Franco Cerutti; Gian Vincenzo Zuccotti; Ana Gomez Gila; Itxaso Rica; Raquel Barrio; Maria Clemente; Maria José López Garcia; Mercedes Rodriguez; Isabel Gonzalez; Juan Pedro Lopez; Mirentxu Oyarzabal; H M Reeser; Roos Nuboer; Pauline Stouthart; Natasa Bratina; Nina Bratanic; Marc de Kerdanet; Jacques Weill; Nicole Ser; Pascal Barat; Anne Marie Bertrand; Jean-Claude Carel; Rachel Reynaud; Regis Coutant; Sabine Baron
Journal:  N Engl J Med       Date:  2012-02-02       Impact factor: 91.245

3.  Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.

Authors:  Tihamer Orban; Brian Bundy; Dorothy J Becker; Linda A DiMeglio; Stephen E Gitelman; Robin Goland; Peter A Gottlieb; Carla J Greenbaum; Jennifer B Marks; Roshanak Monzavi; Antoinette Moran; Philip Raskin; Henry Rodriguez; William E Russell; Desmond Schatz; Diane Wherrett; Darrell M Wilson; Jeffrey P Krischer; Jay S Skyler
Journal:  Lancet       Date:  2011-06-28       Impact factor: 79.321

4.  Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial.

Authors:  Nicole Sherry; William Hagopian; Johnny Ludvigsson; Sunil M Jain; Jack Wahlen; Robert J Ferry; Bruce Bode; Stephen Aronoff; Christopher Holland; David Carlin; Karen L King; Ronald L Wilder; Stanley Pillemer; Ezio Bonvini; Syd Johnson; Kathryn E Stein; Scott Koenig; Kevan C Herold; Anastasia G Daifotis
Journal:  Lancet       Date:  2011-06-28       Impact factor: 79.321

5.  Rituximab, B-lymphocyte depletion, and preservation of beta-cell function.

Authors:  Mark D Pescovitz; Carla J Greenbaum; Heidi Krause-Steinrauf; Dorothy J Becker; Stephen E Gitelman; Robin Goland; Peter A Gottlieb; Jennifer B Marks; Paula F McGee; Antoinette M Moran; Philip Raskin; Henry Rodriguez; Desmond A Schatz; Diane Wherrett; Darrell M Wilson; John M Lachin; Jay S Skyler
Journal:  N Engl J Med       Date:  2009-11-26       Impact factor: 91.245

6.  Synergistic reversal of type 1 diabetes in NOD mice with anti-CD3 and interleukin-1 blockade: evidence of improved immune regulation.

Authors:  Vitaly Ablamunits; Octavian Henegariu; Jakob Bondo Hansen; Lynn Opare-Addo; Paula Preston-Hurlburt; Pere Santamaria; Thomas Mandrup-Poulsen; Kevan C Herold
Journal:  Diabetes       Date:  2011-10-31       Impact factor: 9.461
  6 in total
  2 in total

Review 1.  Extracellular matrix components in the pathogenesis of type 1 diabetes.

Authors:  Marika Bogdani; Eva Korpos; Charmaine J Simeonovic; Christopher R Parish; Lydia Sorokin; Thomas N Wight
Journal:  Curr Diab Rep       Date:  2014-12       Impact factor: 4.810

2.  Depressive Symptoms, Emotion Dysregulation, and Bulimic Symptoms in Youth With Type 1 Diabetes: Varying Interactions at Diagnosis and During Transition to Insulin Pump Therapy.

Authors:  Deborah L Young-Hyman; Claire M Peterson; Sarah Fischer; Jessica T Markowitz; Andrew B Muir; Lori M Laffel
Journal:  J Diabetes Sci Technol       Date:  2016-06-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.